Home » Topics » BioWorld Science

BioWorld Science
RSS

Danish investigators report clinical results for stevioside in diabetes at EASD

Sep. 13, 2001

Corixa and GSK complete resubmission of Bexxar BLA to FDA

Sep. 13, 2001

Interneuron initiates U.S. phase III clinical trial with trospium for overactive bladder

Sep. 13, 2001

Selective iNOS inhibitor protects against IL-1beta-induced rat pancreatic islet damage

Sep. 13, 2001

Poliovirus-based HIV vaccine in development at Iguazu

Sep. 13, 2001

GSK3 inhibitor CT-98023 targets glucose intolerance and insulin resistance of type 2 diabetes

Sep. 13, 2001

Further submissions announced for Visudyne

Sep. 13, 2001

LJP files IND for second clinical candidate

Sep. 13, 2001

New platinum compound licensed by NeoOncoRx, heading for phase III

Sep. 13, 2001

KRX-101 granted fast track status by FDA as treatment for diabetic nephropathy

Sep. 13, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...